Latest News

Immune-modulating drug unexpectedly benefits mice with fatal mitochondrial defect

In a lab devoted to increasing healthy lifespans, the transplant anti-rejection drug rapamycin showed unexpected health benefits and increased survival in a mouse model of a fatal mitochondrial defect. Children with the untreatable condition suffer from brain damage and muscle weakness, and rarely live beyond 6 or 7 years. The drug enables the body to bypass the mitochondrial defect by switching its metabolism to burn fats and amino acids instead of glucose, and thereby reduces toxic byproducts.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • People with epilepsy can benefit from smartphone apps to manage their condition

  • Bow ties and cuttlefish: New insight into a visual super sense

  • Sleep deprivation could reduce intrusive memories of traumatic scenes

  • Computer model shows how nerve cell connections form in visual cortex

  • Males may contribute to offspring's mental development before pregnancy

  • Warts and all: How St. John's Wort can make you sick

  • Hospital-wide program for delirium, alcohol withdrawal and suicide/harm impacts readmission rates

  • Causal pathway may link job stress, sleep disturbances

  • Women's faces get redder at ovulation, but human eyes can't pick up on it

  • Innovative imaging study shows that the spinal cord learns on its own

  •